DEVELOPMENT OF A MECHANISM-BASED DRUG-DISEASE MODELING PLATFORM FOR TYPE 2 DIABETES MELLITUS.

被引：0
|
作者：
Hurtado, F. K. [1 ]
Gaitonde, P. [1 ]
Garhyan, P. [2 ]
Chien, J. Y. [2 ]
Schmidt, S. [1 ]
机构：
[1] Univ Florida, Orlando, FL USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-024
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [1] Mechanism-based disease progression modeling for type 2 diabetes
    Jin, JY
    Abu-Raddad, EJ
    Prince, MJ
    Miller, AR
    Schiebinger, RJ
    DIABETES, 2004, 53 : A580 - A580
  • [2] Development and Qualification of a Drug-Disease Modeling Platform to Characterize Clinically Relevant Endpoints in Type 2 Diabetes Trials
    Gaitonde, Puneet
    Hurtado, Felipe K.
    Garhyan, Parag
    Chien, Jenny Y.
    Schmidt, Stephan
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (04) : 699 - 708
  • [3] DEVELOPMENT OF A MECHANISM-BASED DRUG-DISEASE MODEL TO QUANTIFY POSTMENOPAUSAL OSTEOPOROSIS.
    Madrasi, K.
    Samant, S.
    Kim, M.
    Li, F.
    Voss, S.
    Kehoe, T.
    Schmidt, S.
    Li, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S105 - S105
  • [4] Drug therapy of obesity in type 2 diabetes mellitus.
    Ziegler, O
    Quilliot, D
    DIABETES & METABOLISM, 2000, 26 : 34 - 41
  • [5] Mechanism-based disease progression modeling of type 2 diabetes in Goto-Kakizaki rats
    Wei Gao
    Sébastien Bihorel
    Debra C. DuBois
    Richard R. Almon
    William J. Jusko
    Journal of Pharmacokinetics and Pharmacodynamics, 2011, 38 : 143 - 162
  • [6] Mechanism-based disease progression modeling of type 2 diabetes in Goto-Kakizaki rats
    Gao, Wei
    Bihorel, Sebastien
    DuBois, Debra C.
    Almon, Richard R.
    Jusko, William J.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2011, 38 (01) : 143 - 162
  • [7] GENETIC POLYMORPHISMS ASSOCIATED WITH THE DEVELOPMENT OF TYPE 2 DIABETES MELLITUS.
    Mendonca, M.
    Gomes, S.
    Pereira, A.
    Rodrigues, R.
    Sousa, A.
    Guerra, G.
    Borges, S.
    Rodrigues, M.
    Pereira, D.
    Palma dos Reis, R.
    CARDIOLOGY, 2013, 126 : 42 - 42
  • [8] Incidence and associated factors for cardiovascular disease in type 2 diabetes mellitus.
    Rius, F
    Salinas, I
    Pizarro, E
    Lucas, A
    Romero, R
    Sanmartí, A
    DIABETOLOGIA, 2000, 43 : A280 - A280
  • [9] DRUG-SYSTEMS-DISEASE MODEL TO PREDICT TREATMENT-OUTCOME IN TYPE 2 DIABETES MELLITUS.
    Gaitonde, P.
    Garhyan, P.
    Chien, J. Y.
    Schmidt, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S40 - S41
  • [10] Hepatic steatosis and type 2 diabetes mellitus.
    Clark J.M.
    Diehl A.M.
    Current Diabetes Reports, 2002, 2 (3) : 210 - 215
12345